ENETS 2023
Our Mission
We aim to provide the most precise cancer radiodiagnostics and therapeutics to fight hard-to-treat tumors. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including two phase III studies, combining the company’s high-quality radioisotopes with a range of targeting molecules. We are leveraging our radioisotope leadership to advance a broad pipeline of Targeted Radionuclide Therapies for helping patients live longer and better.
Watch the introduction below and register now to access all of our recordings from ENETS 2023
All of the speakers' videos and presentations are available online upon registration.
A short story of NET therapy – from cold to hot somatostatin
Prof. Kjell Öberg, Professor of Endocrine Oncology, Uppsala University, Finland
We look back on a truly enlightening and sucessful ENETS 2023 conference. We will inform you once the ITM satellite content is available.
Meet the change-makers
Kjell Öberg
Professor, Endocrine Oncology
Senior Professor, Dept of Medical Sciences
Senior Advisor, Dept of Endocrine Oncology - University Hospital
Uppsala University
Aldo Scarpa
Director, ARC-Net Research Centre for Applied Research on Cancer
Director, Dept of Pathology
University and Hospital Trust of Verona
Wolfgang A. Weber
Chair, Dept of Nuclear Medicine
Full Professor, Nuclear Medicine
Technical University of Munich
Heloisa Soares
Associate Professor, Huntsman Cancer Institute
University of Utah
Login
User login
Enter your username and password here in order to log in on the website